Skip to main content
. Author manuscript; available in PMC: 2018 Jan 22.
Published in final edited form as: Integr Obes Diabetes. 2017 Mar 6;3(2):10.15761/IOD.1000170. doi: 10.15761/IOD.1000170

Figure 1.

Figure 1

Scatter plots and regression lines for the change in (A) plasma ZAG concentrations and (B) % weight loss, (C) % body fat loss, and (D) reduction in BMI in subjects who underwent RYGB or VLCD.

Across groups, change in plasma ZAG concentrations was inversely correlated with % weight loss (r= −0.70, p<0.05), amount of weight loss (r= −0.58, p<0.05), % body fat loss (r= −0.68, p<0.015), and reduction in BMI (r= −0.60, p<0.05). Note that above a certain threshold of weight loss, ZAG begins to decrease for those in the VLCD group.